Recently added articles from Product Management Today:
Marketing strategies for clinical trial recruitment and patient retention: behind every new medicine are the volunteers who take part in clinical research studies; however, the number of people who participate in clinical trials is quite small. This article details how product managers can help to build clinical trial awareness.(PMT in Practice)
Dec 01, 2006; ... Every year, several million people participate in clinical trials to support new drug applications (NDAs) submitted to the FDA. This level of participation represents less than 10% of the more than 60 million people who have severe, chronic, and life-threatening illnesses in the United ...
Globalization of field-based medical science liaison programs: the scientific basis for global success: the deployment of field-based medical science liaisons (MSLs) has become common practice in the United States. However, transplanting this same model into foreign markets is not an easy task. When using MSL programs in overseas markets, they must conform to local regulatory guidelines, employment policies, and market subtleties.(PMT in Practice)
Dec 01, 2006; ... The global pharmaceutical market is dominated by the United States. However, markets outside of the United States (ex-U.S. markets) account for 54% of total worldwide pharmaceutical sales and represent a significant future growth opportunity for the industry. Over the past decade, medical ...
Plug in the brand plan: adding a dash of electronic marketing to any overarching brand strategy will not only help focus disparate marketing tactics into a cohesive plan, but it will also help drive the message home by increasing its relevance and reach.(Eye on E-Marketing)
Dec 01, 2006; ... By now, most product managers have completed the 2007 planning process and are awaiting approval of the final budgets for next year. Before anyone grabs a glass of champagne and toasts their future success, they should ask one question: Is the 2007 brand plan plugged in? ...
Physicians still highly value professional medical societies.(Guest Viewpoint)(Viewpoint essay)
Dec 01, 2006; ... I was recently asked by a product manager about the value that physicians gain in aligning themselves with their respective medical societies. Although professional societies for physicians differ in their programming and execution, they have at their heart a common commitment to improving ...
Who are those guys? Using anonymized patient-level intelligence to size and characterize an undiagnosed population: anonymized patient-level intelligence can be used to provide more accurate insights into the prediabetic population.(Industry Intelligence)
Dec 01, 2006; ... In the film, "Butch Cassidy and the Sundance Kid," Butch Cassidy frets over the mysterious posse pursuing them and repeatedly asks Sundance, "Who are those guys?" More than one pharmaceutical company brand team is surely asking the same question--this time with respect to patients with ...
The Seventh Annual PMT Reader's Choice Awards.(PMT Reader's Choice Awards)
Dec 01, 2006 ... What makes for an excellent ad? Is it creativity, stopping power, effectiveness, a message? Are all of these elements necessary? Is one enough? Ad agencies are under an intense amount of pressure. They are competing against other agencies and other types of media for a limited ...
Pharmaceutical representatives can deliver the brand promise: the sales representative plays a critical role in the marketing and branding processes. To do this, pharmaceutical reps in the field must constantly be in tune with the purpose of the companies they represent.(PMT in Practice)
Nov 01, 2006; ... One could say it is a perfect storm. Thanks to the Internet, consumers have access to more information than at any time in the history of the health care industry. Pharmaceutical companies have invested hundreds of millions of dollars in marketing tactics designed to increase consumer ...
Creating brand connections through deeper understanding of the customer: focus groups and in-depth interviews are important tools that provide critical information for marketing strategies. However, new and innovative tools and processes are available that can give product managers greater an even customer understanding.(PMT in Practice)
Nov 01, 2006; ... If a group of pharmaceutical brand managers are asked what they want from their marketing, the answer will be clear: "A campaign that makes my brand stand out from the competition and drives sales." With growing cost pressures, less differentiation among products on the market, and shorter ...
Easy doesn't count: direct-to-consumer advertising remains a controversial medium in the world of pharmaceutical marketing. This column examines how the industry can use DTC advertising to its advantage.(DTC IQ)(Column)
Nov 01, 2006; ... I have a friend with one of the all-time-best signatures for his E-mail: Easy Doesn't Count. He's a hard-charging guy, who has programmed his E-mail account to place that phrase at the end of every communication to inspire his employees and coworkers to go the extra mile. It's ...
Changing for the better: women, opportunity, and the pharmaceutical business.(Guest Viewpoint)(Viewpoint essay)
Nov 01, 2006; ... I recently unearthed a photograph from my first week in the pharmaceutical business as a rep for Abbott Labs (Abbott Park, IL), circa 1981. I'm wearing a dark navy suit and a white oxford-cloth shirt, with a floppy silk bow knotted loosely around my neck. At the time, Dress for Success ...
Patient assistance programs still needed after part D.(Health Care Briefs)
Nov 01, 2006; ... Patient assistance programs (PAPs) partially subsidize or dispense free drugs to uninsured or underinsured individuals. However, with the advent of Medicare part D, some believed that PAPs would possibly disappear, owing to the theory that poor patients who previously could not afford drug ...
Federal government eases drug importation policies.(Health Care Briefs)(Department of Homeland Security)
Nov 01, 2006; ... The Department of Homeland Security recently announced it will halt the confiscation of drugs mailed to U.S. consumers from Canadian pharmacies. Instead, the Customs and Border Protection (CBP) agency, operated by the Department, will randomly sample shipments to identify counterfeit and ...
Sizing up opportunities in the metabolic syndrome market: anonymized patient-level intelligence can be used to more accurately quantify and characterize opportunity in the metabolic syndrome market.(Industry Intelligence)
Nov 01, 2006; ... Metabolic syndrome is defined as a collection of health risks that increases a patient's chances of developing heart disease, stroke, and diabetes. The condition is becoming increasingly common in the United States: According to the American Heart Association, Dallas, more than 50 million ...
Erratum.(Correction notice)
Nov 01, 2006 ... In the September issue, the DTC IQ article by Joe Meadows of Catalina Health Resource was printed with the wrong title. The ...
Asset acquisition.(Industry News: A summary of recent industry happenings, from corporate acquisitions to collaborations to agency news to new products, all of interest to pharmaceutical product managers.)(mergers of TMS Health and TMS Professional Markets Group)(Brief article)
Nov 01, 2006 ... TMS Health acquired TMS Professional Markets Group, a division of Access Worldwide Communications, all located in Boca Raton, Florida. The acquisition was led by Lee Edelstein (founder of TMS Health, right) and ...
Innovative on-line resource.(Industry News: A summary of recent industry happenings, from corporate acquisitions to collaborations to agency news to new products, all of interest to pharmaceutical product managers.)(internet launch of Excerpta Medica)(www.ctjournalclub.com)(Brief article)
Nov 01, 2006 ... Excerpta Medica, Bridgewater, New Jersey, has launched the Clinical Therapeutics Journal Club website (www.ctjournalclub.com). The on-line ...
Skin cancer treatment.(FDA Focus: A monthly review of FDA activity, including issuances of approvals, labeling changes, and guidances.)(Brief article)
Nov 01, 2006 ... The FDA granted orphan drug approval to Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma, to be used when the disease persists, worsens, ...
Irritability and autism.(FDA Focus: A monthly review of FDA activity, including issuances of approvals, labeling changes, and guidances.)(Brief article)
Nov 01, 2006 ... Janssen, L.P. (Titusville, NJ) announced FDA approval of Risperdal (risperidone) orally disintegrating tablets, for the symptomatic treatment of irritability in autistic children and adolescents. ...
Orphan drug designation.(FDA Focus: A monthly review of FDA activity, including issuances of approvals, labeling changes, and guidances.)(Brief article)
Nov 01, 2006 ... Agennix (Houston) received orphan drug designation for the oral formulation of Talactoferrin alfa ...
Drug for colorectal cancer.(FDA Focus: A monthly review of FDA activity, including issuances of approvals, labeling changes, and guidances.)(Brief article)
Nov 01, 2006 ... The FDA granted accelerated approval to Vectibix (panitumumab), manufactured by Amgen, Inc. (Thousand Oaks, CA), for the treatment of patients with colorectal cancer that has ...